Skip to main content
. 2019 Dec 14;36(2):193–206. doi: 10.1007/s12550-019-00381-9

Table 2.

Concentration of deoxynivalenol (DON) and DON-15-β-D-O-glucuronide (DON-15GlcA) in positive urine samples, unadjusted for density, divided by school year and sex

School year Sex Number DON (ng/ml) DON-15GlcA (ng/ml)
% > LOQ1 Mean2 Median Max % > LOQ1 Mean2 Median Max
5 Female 165 6.7 8.4 ± 8.8 18.7 27.6 10.9 15.0 ± 8.5 12.4 38.3
Male 166 1.8 27.1 ± 38.4 55.4 102.3 13.3 16.3 ± 14.3 12.1 58.7
8 Female 232 3.9 23.1 ± 23.0 32.7 82.4 6.0 19.8 ± 13.5 14.8 45.4
Male 179 6.2 13.0 ± 18.2 46.6 46.6 7.9 21.5 ± 15.3 19.2 59.7
11 Female 219 4.6 16.8 ± 18.7 18.6 65.1 6.4 19.6 ± 10.0 16.3 40.6
Male 135 3.0 10.5 ± 15.4 33.6 33.6 11.1 14.9 ± 6.7 13.3 29.4
All 1096 4.8 16.0 ± 21.7 26.2 102.3 9.0 17.5 ± 11.8 13.6 59.7

Values between LOD and LOQ were replaced with ½ LOQ LOD for DON, 1.7 ng/ml, and for DON-15GlcA, 1.0 ng/ml

1LOQ (limit of quantitation) LOQ for DON, 5.6 ng/ml, and for DON-15GlcA, 3.3 ng/ml

2Mean is calculated in positive samples, excluding values < LOD (limit of detection)